Search

Your search keyword '"Krystal, Andrew D."' showing total 65 results

Search Constraints

Start Over You searched for: Author "Krystal, Andrew D." Remove constraint Author: "Krystal, Andrew D." Database eScholarship Remove constraint Database: eScholarship
65 results on '"Krystal, Andrew D."'

Search Results

1. Cortical Synchrony and Information Flow during Transition from Wakefulness to Light Non-Rapid Eye Movement Sleep

2. International Consensus Statement on Obstructive Sleep Apnea

3. Alliance for Sleep Clinical Practice Guideline on Switching or Deprescribing Hypnotic Medications for Insomnia.

4. Long-Term Use of Insomnia Medications: An Appraisal of the Current Clinical and Scientific Evidence

5. Wake Up America: National Survey of Patients’ and Physicians’ Views and Attitudes on Insomnia Care

6. Do Insomnia Treatments Improve Daytime Function?

7. Should Trazodone Be First-Line Therapy for Insomnia? A Clinical Suitability Appraisal

8. What Should Be the Focus of Treatment When Insomnia Disorder Is Comorbid with Depression or Anxiety Disorder?

9. Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression

10. A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials

11. Randomized controlled trial of digital cognitive behavior therapy for prenatal insomnia symptoms: effects on postpartum insomnia and mental health

12. Telemedicine-delivered cognitive-behavioral therapy for insomnia in alcohol use disorder (AUD): study protocol for a randomized controlled trial

13. Overnight Delta Dynamics Associated with Daytime Psychomotor Performance in Adults with Insomnia and Healthy Controls

14. Closed-loop neuromodulation in an individual with treatment-resistant depression

15. Optimizing computation of overnight decline in delta power: Evidence for slower rate of decline in delta power in insomnia patients

16. State-dependent responses to intracranial brain stimulation in a patient with depression

17. Mutations in Metabotropic Glutamate Receptor 1 Contribute to Natural Short Sleep Trait

18. Distributed Subnetworks of Depression Defined by Direct Intracranial Neurophysiology.

19. Mutations in Metabotropic Glutamate Receptor 1 Contribute to Natural Short Sleep Trait.

20. Is cellular energy monitoring more responsive to hypoxia than pulse oximetry?

21. Is cellular energy monitoring more responsive to hypoxia than pulse oximetry?

22. Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)

23. An exploratory analysis of the association of circadian rhythm dysregulation and insomnia with suicidal ideation over the course of treatment in individuals with depression, insomnia, and suicidal ideation.

24. A randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedonia

25. Genetics of the human circadian clock and sleep homeostat

26. Sleep therapeutics and neuropsychiatric illness

27. Genetics of the human circadian clock and sleep homeostat.

28. Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical Trial.

29. The assessment and management of insomnia: an update.

30. Prevalence of obstructive sleep apnea in suicidal patients with major depressive disorder.

31. An Electrophysiological Biomarker That May Predict Treatment Response to ECT

32. Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers.

33. Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers

34. A review of the associations between obstructive sleep apnea and hypertensive disorders of pregnancy and possible mechanisms of disease

35. Screening extremely obese pregnant women for obstructive sleep apnea

36. Obstructive Sleep Apnea in Pregnant Women

37. Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression.

38. The relationship of person-specific eveningness chronotype, greater seasonality, and less rhythmicity to suicidal behavior: A literature review.

39. Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder

40. Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder.

41. Cognitive Behavioral Insomnia Therapy for Those With Insomnia and Depression: A Randomized Controlled Clinical Trial

42. Are Patients with Childhood Onset of Insomnia and Depression More Difficult to Treat Than Are Those with Adult Onsets of These Disorders? A Report from the TRIAD Study.

43. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.

44. Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA.

45. Insomnia Patients With Objective Short Sleep Duration Have a Blunted Response to Cognitive Behavioral Therapy for Insomnia

46. Sleep disturbances in adolescents with ADHD: A systematic review and framework for future research

47. Sleep and Mood: Chicken or Egg?

48. Sleep and Mood: Chicken or Egg?

49. Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale

50. Kappa‐Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials

Catalog

Books, media, physical & digital resources